Pegvisomant in severe, treatment-resistant thyroid eye disease: a case report.

Köröskényi L, Szkibák N, Steiber Z, Barna S, Nagy EB, Karányi Z, Balla J, Bodor M, Nagy EV, Erdei A

Open source

DOI
10.7573/dic.2026-7-5
Published
2026
Container
Drugs in context
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7573/dic.2026-7-5,
  title = {Pegvisomant in severe, treatment-resistant thyroid eye disease: a case report.},
  author = {Köröskényi L and Szkibák N and Steiber Z and Barna S and Nagy EB and Karányi Z and Balla J and Bodor M and Nagy EV and Erdei A},
  year = {2026},
  journal = {Drugs in context},
  doi = {10.7573/dic.2026-7-5},
  url = {https://doi.org/10.7573/dic.2026-7-5}
}

RIS

TY  - JOUR
TI  - Pegvisomant in severe, treatment-resistant thyroid eye disease: a case report.
AU  - Köröskényi L
AU  - Szkibák N
AU  - Steiber Z
AU  - Barna S
AU  - Nagy EB
AU  - Karányi Z
AU  - Balla J
AU  - Bodor M
AU  - Nagy EV
AU  - Erdei A
PY  - 2026
JO  - Drugs in context
DO  - 10.7573/dic.2026-7-5
UR  - https://doi.org/10.7573/dic.2026-7-5
ER  - 

APA

L, K., N, S., Z, S., S, B., EB, N., Z, K., J, B., M, B., EV, N., & A, E. (2026). Pegvisomant in severe, treatment-resistant thyroid eye disease: a case report.. Drugs in context. https://doi.org/10.7573/dic.2026-7-5

Source records